Therapeutic efficacy of Pudilan Xiaoyan Oral Liquid (PDL) for COVID-19 in vitro and in vivo

Signal Transduct Target Ther. 2020 May 8;5(1):66. doi: 10.1038/s41392-020-0176-0.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use
  • Betacoronavirus / drug effects*
  • COVID-19
  • Chlorocebus aethiops
  • Coronavirus Infections / drug therapy*
  • Disease Models, Animal
  • Drugs, Chinese Herbal / pharmacology*
  • Drugs, Chinese Herbal / therapeutic use*
  • Mice
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • Random Allocation
  • SARS-CoV-2
  • Treatment Outcome
  • Vero Cells

Substances

  • Antiviral Agents
  • Drugs, Chinese Herbal
  • Pudilan xiaoyan